El Vínculo El Vínculo.
Direct award European Union Supplies

Ex-Ante-Transparenzbekanntmachung § 130a Abs. 8 SGB V TYSABRI 150 mg Inj.-Lsg.i.e.Fertigspritze 2xSC(R) Wirkstoff: Natalizumab ATC-Code: L04AG03

Buyer: AOK Bayern - Die Gesundheitskasse

Published
22 May 2025
Procedure
Negotiated procedure
Lots
1
Notice number
00329309-2025
Reference
c7d8b731-ebb0-4d98-a328-45bd2d006e4d
Official source
Official source

CPV codes

Description

Arzneimittelrabattvertrag § 130a Abs. 8 SGB V Arzneimittelbezeichnung: TYSABRI 150 mg Inj.-Lsg.i.e.Fertigspritze 2xSC(R) Wirkstoff: Natalizumab ATC-Code: L04AG03

Awards

Awarded toAmountDate
Biogen GmbH

Official publications

Other tenders from AOK Bayern - Die Gesundheitskasse

Frequently asked questions

Who is the buyer of this tender?
The contracting authority is AOK Bayern - Die Gesundheitskasse (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.